Brainstorm Cell Therapeutics | BCLI - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Biogen USD 1.28B 2.1B 2026-06
Brainstorm Cell Therapeutics USD 22K 7K 2026-06
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 255.27M 125.43M 2026-06
Gilead Sciences USD 7.63B 64M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Mesoblast USD 129.57M 31.58M 2025-12